Estrella Immunopharma, Inc. (ESLA) stock
ESLANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ESLAW
Financials through Q1 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.33+0.00 (+0.39%)
Close on Nov 18, 2026Market cap $14.48MP/E –Yield –
Estrella Immunopharma market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Estrella Immunopharma's market cap was $21.52M on Nov 11, 2026, against $77.25M a year earlier. Over the last 5 years it ranged from $2.27M to $88.60M, with a median of $33.94M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $21.52M | -62.3% |
| 2025 | Dec 31, 2025 | $57.11M | +30.0% |
| 2024 | Dec 31, 2024 | $43.93M | +12.4% |
| 2023 | Dec 29, 2023 | $39.07M | +167.5% |
| 2022 | Dec 30, 2022 | $14.61M | +3.8% |
| 2021 | Dec 31, 2021 | $14.07M | – |
See a number that looks wrong?